[10] Devine first joined Canadian Blood Services (CBS) in 1999, following its creation as a result of the Krever Inquiry, as the executive director of research and development.
[16] An AABB member since 1998, Dana recognized the challenges that the field was facing, including the maintenance of a stable and adequate blood supply, ensuring a sufficient and well-trained workforce, and advancing research.
[17] For her "critical scientific leadership to Canada’s blood system," Devine was elected a fellow of the Canadian Academy of Health Sciences in 2015.
[6] Devine joined the University of British Columbia's Department of Pathology and Laboratory Medicine in 2000, and served as the Graduate Studies Program Director.
[18] Devine's research specialties were in blood system management and quality improvement,[2] platelet biology and coagulation, and complement biochemistry.
[10] She was President of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, where her projects focused on improving the processing, quality, and utilization of conventional blood components.
[7] Devine chaired the medical advisory committee for the largest blood operator in the United States, the American Red Cross.
[26] Her most cited paper is title "Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions", with over 400 citations.